炎症性腸疾患と障害のジャーナル

Inflammatory Bowel Disease and Amebiasis

Abstract

Sanyour Joyce, Nakhoul Mary, Saniour Philippe and Abou Rached Antoine

Amebiasis affects around 500 million people in the world and could lead to 100,000 deaths/year from amebic dysentery and/or liver abscess. It is prevalent in developing countries like the Southern and Eastern Mediterranean region, and more in the Indian subcontinent, Southern and Western Africa and South America where prevalence could reach 50%. It is mainly caused by Entamoeba Hystolitica (EH). Underlying conditions associated with immunosuppression including diabetes mellitus and tuberculosis are present in more than 50% of patients.